US 10870837
Fusion proteins comprising enzyme replacement therapy enzymes
granted A61KA61K38/00A61K47/68
Quick answer
US patent 10870837 (Fusion proteins comprising enzyme replacement therapy enzymes) held by DENALI THERAPEUTICS INC. expires Mon Dec 17 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- DENALI THERAPEUTICS INC.
- Grant date
- Tue Dec 22 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 17 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 47
- CPC classes
- A61K, A61K38/00, A61K47/68, A61P, A61P3/00